The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors
Open accessAbstract
Histone deacetylase inhibitors (HDACis) inhibit tumor cell growth and survival, possibly through their ability to regulate the expression of specific proliferative and/or apoptotic genes. However, the HDACi-regulated genes necessary and/or sufficient for their biological effects remain undefined. We demonstrate that the HDACis suberoylanilide hydroxamic acid (SAHA) and depsipeptide regulate a highly overlapping gene set with at least 22% of genes showing altered expression over a 16-h culture period. SAHA and depsipeptide coordinately regulated the expression of several genes within distinct apoptosis and cell cycle pathways. Multiple genes within the Myc, type β TGF, cyclin/cyclin-dependent kinase, TNF, Bcl-2, and caspase pathways were regulated in a manner that favored induction of apoptosis and decreased cellular proliferation.APAF-1, a gene central to the intrinsic apoptotic pathway, was induced by SAHA and depsipeptide and shown to be important, but not essential, for HDACi-induced cell death. Overexpression of p16 INK4A and arrest of cells in G 1 can suppress HDACi-mediated apoptosis. Although p16 INK4A did not affect the genome-wide transcription changes mediated by SAHA, a small number of apoptotic genes, including BCLXL and B-MYB, were differentially regulated in a manner consistent with attenuated HDACi-mediated apoptosis in arrested cells. We demonstrate that different HDACi alter transcription of a large and common set of genes that control diverse molecular pathways important for cell survival and proliferation. The ability of HDACi to target multiple apoptotic and cell proliferation pathways may provide a competitive advantage over other chemotherapeutic agents because suppression/loss of a single pathway may not confer resistance to these agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Self-citationSmyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Self-citationThe Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Roles of CHOP/GADD153 in endoplasmic reticulum stress
Oyadomari, S., & Mori, M. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401373 · Cited by 2,828
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Self-citationThe Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138
Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
Self-citationInactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
(2002) · PubMed · Cited by 732
Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization
Lassus, P., Opitz-Araya, X., & Lazebnik, Y. (2002) · Science · doi:10.1126/science.1074721 · Cited by 719
Two major Smad pathways in TGF‐β superfamily signalling
Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T., & Miyazono, K. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00599.x · Cited by 662
(1996) · Europe PMC (PubMed Central) · Cited by 659
Apoptotic and autophagic cell death induced by histone deacetylase inhibitors
Shao, Y., Gao, Z., Marks, P. A., & Jiang, X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408345102 · Cited by 605
Self-citationModulation of life and death by the TNF receptor superfamily
Baker, S. J., & Reddy, E. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202568 · Cited by 534
Mitsiades, C. S., Mitsiades, N. S., McMullan, C. J., Poulaki, V., Shringarpure, R., Hideshima, T., Akiyama, M., Chauhan, D., Munshi, N., Gu, X., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536759100 · Cited by 531
Self-citation(2003) · PubMed · Cited by 519
Ungerstedt, J. S., Sowa, Y., Xu, W.-S., Shao, Y., Dokmanovic, M., Perez, G., Ngo, L., Holmgren, A., Jiang, X., & Marks, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408732102 · Cited by 503
Self-citationRuefli, A. A., Ausserlechner, M. J., Bernhard, D., Sutton, V. R., Tainton, K. M., Kofler, R., Smyth, M. J., & Johnstone, R. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191208598 · Cited by 488
Self-citationHistone Deacetylase Inhibitors
(2004) · Advances in Cancer Research · doi:10.1016/s0065-230x(04)91004-4 · Cited by 415
Ekert, P., Silke, J., & Vaux, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400594 · Cited by 385
Mariadason, J. M., Corner, G. A., & Augenlicht, L. H. (2000) · PubMed · Cited by 375
Vrana, J. A., Decker, R. H., Johnson, C. R., Wang, Z., Jarvis, W. D., Richon, V. M., Ehinger, M., Fisher, P. B., & Grant, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203176 · Cited by 284
Self-citationNovel mechanisms of apoptosis induced by histone deacetylase inhibitors.
Peart, M. J., Tainton, K. M., Ruefli, A. A., Dear, A. E., Sedelies, K. A., O’Reilly, L. A., Waterhouse, N. J., Trapani, J. A., & Johnstone, R. W. (2003) · PubMed · Cited by 233
Self-citationTirone, F. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1062 · Cited by 214
Sanjo, H., Kawai, T., & Akira, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29066 · Cited by 205
DNA Microarrays: A Molecular Cloning Manual
(2003) · Journal of Proteome Research · doi:10.1021/pr030764o · Cited by 204
Angell, J. E., Lindner, D. J., Shapiro, P. S., Hofmann, E. R., & Kalvakolanu, D. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003929200 · Cited by 200
Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes
Vadlamudi, R. K., Bagheri-Yarmand, R., Yang, Z., Balasenthil, S., Nguyen, D., Sahin, A. A., den Hollander, P., & Kumar, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.022 · Cited by 189
Glick, R. D., Swendeman, S. L., Coffey, D. C., Rifkind, R. A., Marks, P. A., Richon, V. M., & Quaglia, M. P. L. (1999) · PubMed · Cited by 185
Self-citationSelvakumaran, M., Lin, H. K., Sjin, R. T., Reed, J. C., Liebermann, D. A., & Hoffman, B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2352 · Cited by 183
Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β
Kee, B. L., Rivera, R. R., & Murre, C. (2001) · Nature Immunology · doi:10.1038/85303 · Cited by 167
Calpains Can Do It Alone: Implications for Cancer Therapy
guicciardi, M. E., & Gores, G. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.2.349 · Cited by 164
Afonja, O., Juste, D., Das, S., Matsuhashi, S., & Samuels, H. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207983 · Cited by 154
Harada, H., Chan, C. M., Loesch, A., Unwin, R. J., & Burnstock, G. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00911.x · Cited by 149
Up-Regulation of p21WAF1/CIP1 by Histone Deacetylase Inhibitors Reduces Their Cytotoxicity
Burgess, A., Pavey, S. J., Warrener, R., Hunter, L.-J. K., Piva, T. J., Musgrove, E. A., Saunders, N. A., Parsons, P. G., & Gabrielli, B. G. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12311-5 · Cited by 138
ZIP Kinase Triggers Apoptosis from Nuclear PML Oncogenic Domains
Kawai, T., Akira, S., & Reed, J. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6174-6186.2003 · Cited by 124
Instrumental Activation of Bid by Caspase-1 in a Transgenic Mouse Model of ALS
Guégan, C. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1136 · Cited by 104
BNips: A group of pro-apoptotic proteins in the Bcl-2 family
Zhang, H. M., Cheung, P. K., Yanagawa, B., McManus, B. M., & Yang, D. (2003) · APOPTOSIS · doi:10.1023/a:1023616620970 · Cited by 81
Cook, T. A., & Urrutia, R. A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.4.g513 · Cited by 81
Phosphorus-Based SAHA Analogues as Histone Deacetylase Inhibitors
Kapustin, G. V., Fejér, G., Gronlund, J. L., McCafferty, D. G., Seto, E., & Etzkorn, F. A. (2003) · Organic Letters · doi:10.1021/ol035056n · Cited by 57
Inhibition of PKCα induces a PKCδ-dependent apoptotic program in salivary epithelial cells
Matassa, A. A., Kalkofen, R. L., Carpenter, L., Biden, T. J., & Reyland, M. E. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401149 · Cited by 47
Ausserlechner, M. J., Obexer, P., Wiegers, G. J., Hartmann, B. L., Geley, S., & Kofler, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008188200 · Cited by 41
Calbó, J., Marotta, M., Cascalló, M., Roig, J. M., Gelpí, J. L., Fueyo-Margareto, J., & Mazo, A. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700374 · Cited by 40
Cited by
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Self-citationAnticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Self-citationHistone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
Self-citationHistone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
“…of colon, bladder, kidney, prostate and breast, cultured for up to 48 h with butyrate, TSA, MS-275, vorinostat or FK228 (depsipeptide) using twofold change as the cut-off value (Chambers et al., 2003; Glaser et al., 2003; Mitsiades et al., 2004; Peart et al., 2005; Sasakawa et al., 2005).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Peart, M. J., Smyth, G. K., van Laar, R. K., Bowtell, D. D., Richon, V. M., Marks, P. A., Holloway, A. J., & Johnstone, R. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-02-28
- Volume
- 102
- Issue
- 10
- Pages
- 3697-3702
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2024425375
- Cited by
- 539
- References
- 48
- FWCI
- 14.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.